These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 16636230
1. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk. Kumar S, Savitz S, Schlaug G, Caplan L, Selim M. Neurology; 2006 Apr 25; 66(8):1153-8; discussion 1135. PubMed ID: 16636230 [Abstract] [Full Text] [Related]
2. Prior antiplatelet use and infarct volume in ischemic stroke. Ovbiagele B, Buck BH, Liebeskind DS, Starkman S, Bang OY, Ali LK, Villablanca JP, Salamon N, Yun SW, Pineda S, Saver JL. J Neurol Sci; 2008 Jan 15; 264(1-2):140-4. PubMed ID: 17854835 [Abstract] [Full Text] [Related]
3. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome. Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH. Clin Neuropharmacol; 2011 Jan 15; 34(6):234-40. PubMed ID: 21996648 [Abstract] [Full Text] [Related]
4. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity. Selim M, Savitz S, Linfante I, Caplan L, Schlaug G. BMC Neurol; 2005 Jun 10; 5(1):10. PubMed ID: 15949043 [Abstract] [Full Text] [Related]
5. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R. Ann Neurol; 2000 Nov 10; 48(5):713-22. PubMed ID: 11079534 [Abstract] [Full Text] [Related]
6. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke. Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH. Basic Clin Pharmacol Toxicol; 2012 Apr 10; 110(4):370-7. PubMed ID: 22023326 [Abstract] [Full Text] [Related]
7. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Schellinger PD, Fiebach JB, Jansen O, Ringleb PA, Mohr A, Steiner T, Heiland S, Schwab S, Pohlers O, Ryssel H, Orakcioglu B, Sartor K, Hacke W. Ann Neurol; 2001 Apr 10; 49(4):460-9. PubMed ID: 11310623 [Abstract] [Full Text] [Related]
8. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG. Neurology; 2007 May 15; 68(20):1687-93. PubMed ID: 17502550 [Abstract] [Full Text] [Related]
10. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes. Yu AY, Keezer MR, Zhu B, Wolfson C, Côté R. Cerebrovasc Dis; 2009 May 15; 27(4):398-402. PubMed ID: 19276623 [Abstract] [Full Text] [Related]
18. Early ischemic lesion recurrence within a week after acute ischemic stroke. Kang DW, Latour LL, Chalela JA, Dambrosia J, Warach S. Ann Neurol; 2003 Jul 15; 54(1):66-74. PubMed ID: 12838521 [Abstract] [Full Text] [Related]
19. 3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke. Kosior RK, Wright CJ, Kosior JC, Kenney C, Scott JN, Frayne R, Hill MD. Cerebrovasc Dis; 2007 Jul 15; 24(4):361-8. PubMed ID: 17690549 [Abstract] [Full Text] [Related]
20. The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials. Barber PA, Parsons MW, Desmond PM, Bennett DA, Donnan GA, Tress BM, Davis SM. J Neuroimaging; 2004 Apr 15; 14(2):123-32. PubMed ID: 15095557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]